Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Birth control pills can improve or cause acne and hair issues, with improvements more common, and may affect skin pigmentation.

Oral spironolactone and isotretinoin are effective for treating acne.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

Cyproterone slightly inhibited hair growth in castrated mice, while tamoxifen significantly inhibited hair growth in castrated mice but not in normal mice.

In 1981, the punch graft technique was the main method for hair transplantation, and medical treatments for baldness were not very effective.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Ferulic acid may help control menstrual cycle-related epilepsy by affecting female hormones.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Female androgenic alopecia causes hair thinning in women, especially after menopause, and affects their mental well-being.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Female pattern hair loss is different from male pattern hair loss and has unclear genetic causes.

Dr. Rodney Sinclair uses a detailed grading system to diagnose female pattern hair loss, recommends daily spironolactone and minoxidil for treatment, and believes genetics play a role in the condition.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

New treatments for male hypogonadism are effective and should be personalized.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

A 5-year-old girl with McCune-Albright syndrome grew abnormal hair due to the drug tamoxifen.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.